Reach Us +1-217-403-9671
Efficiency Of Two-stage Designs For Crossover Bioequivalence Trials | 19790
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

Sven Schnaidt
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
B ioequivalence studies aim at showing in vivo that two pharmaceutical products are comparable with respect to their bioavailability. Usually, the assumptions about the true effect and variability are uncertain, which makes it particularly difficult to calculate the required sample size assuring a predefined power. Recent regulatory guidelines on bioequivalence studies acknowledge these difficulties and accept application of two-stage designs in this context. Specifically, two approaches are described in these guidelines: group sequential designs with pre-specified fixed sample sizes in each of the two stages, and adaptive designs where the sample size of stage 2 is calculated based on the information observed in the interim analysis. The Canadian Guideline even gives recommendations for a specific design, namely to use a method proposed by Potvin et al. when applying an adaptive design. However, a number of alternative two-stage designs have been proposed that allow an adaption in sample size based on interim results. Up to now, these approaches have only been discussed for superiority and non-inferiority trials. We systematically compare the method described by Potvin et al. to alternative adaptive and group-sequential methods in the situation of two-way crossover bioequivalence trials. The performance characteristics in terms of type I error rate, power, and expected sample size are investigated. Results are discussed to give recommendations for future planning of two-stage bioequivalence trials
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version